These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15886048)

  • 1. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
    Yakar S; Leroith D; Brodt P
    Cytokine Growth Factor Rev; 2005; 16(4-5):407-20. PubMed ID: 15886048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies involving the GH-IGF axis: Lessons from IGF-I and IGF-I receptor gene targeting mouse models.
    Yakar S; Pennisi P; Kim CH; Zhao H; Toyoshima Y; Gavrilova O; LeRoith D
    J Endocrinol Invest; 2005; 28(5 Suppl):19-22. PubMed ID: 16114270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?
    Meinbach DS; Lokeshwar BL
    Urol Oncol; 2006; 24(4):294-306. PubMed ID: 16818181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like growth factor axis in cell cycle progression.
    Dupont J; Pierre A; Froment P; Moreau C
    Horm Metab Res; 2003; 35(11-12):740-50. PubMed ID: 14710353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiology of somatotropic axis: interest of gene inactivation experiments].
    Le Bouc Y; Gicquel C; Holzenberger M
    Bull Acad Natl Med; 2003; 187(7):1225-43; discussion 1244-7. PubMed ID: 15146601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of IGF-I deficiency: lessons from mouse models.
    Yakar S; Sun H; Zhao H; Pennisi P; Toyoshima Y; Setser J; Stannard B; Scavo L; Leroith D
    Pediatr Endocrinol Rev; 2005 Sep; 3(1):11-9. PubMed ID: 16369209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of systemic and local IGF-I: lessons from animal models.
    LeRoith D
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():739-43. PubMed ID: 18317445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of insulin and insulin-like growth factor-I in mammalian ageing.
    Richardson A; Liu F; Adamo ML; Van Remmen H; Nelson JF
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):393-406. PubMed ID: 15261845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies].
    Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L
    Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings.
    Bartke A
    Aging Cell; 2008 Jun; 7(3):285-90. PubMed ID: 18346217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum from heifer calves treated with bovine growth hormone affects the rate of proliferation of C2C12 myogenic cells dependent on the plane of nutrition: the role of insulin-like growth factor-I and IGF-binding proteins-2 and -3.
    Oksbjerg N; Nissen PM; Vestergaard M
    J Anim Physiol Anim Nutr (Berl); 2006 Jun; 90(5-6):177-84. PubMed ID: 16684137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding proteins initiate cell death and extracellular matrix remodeling in the mammary gland.
    Flint DJ; Boutinaud M; Tonner E; Wilde CJ; Hurley W; Accorsi PA; Kolb AF; Whitelaw CB; Beattie J; Allan GJ
    Domest Anim Endocrinol; 2005 Aug; 29(2):274-82. PubMed ID: 15998501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the IGF1 axis in cancer proliferation.
    Bruchim I; Attias Z; Werner H
    Expert Opin Ther Targets; 2009 Oct; 13(10):1179-92. PubMed ID: 19663648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse.
    Yakar S; Pennisi P; Zhao H; Zhang Y; LeRoith D
    Novartis Found Symp; 2004; 262():3-9; discussion 9-18, 265-8. PubMed ID: 15562820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
    Hofmann F; García-Echeverría C
    Drug Discov Today; 2005 Aug; 10(15):1041-7. PubMed ID: 16055020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.